Jump Financial, LLC Passage Bio, Inc. Transaction History

Jump Financial, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$1.63 - $3.46 $72,698 - $154,316	-44,600 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$2.66 - $6.49 $15,694 - $38,291	5,900 Added 15.25%	44,600 $138,000
Q4 2021 Feb 10, 2022	BUY	$6.24 - $10.2 $37,440 - $61,199	6,000 Added 18.35%	38,700 $246,000
Q3 2021 Nov 12, 2021	BUY	$9.73 - $15.52 $188,762 - $301,088	19,400 Added 145.86%	32,700 $326,000
Q2 2021 Aug 13, 2021	BUY	$12.44 - $19.45 $165,452 - $258,685	13,300 New	13,300 $176,000

38.7M

7.7K

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $32.1M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.